Next-gen therapies for cancer, dementia and more fast-tracked with new facility

News Artificial Intelligence General Updates

Date: 28th Aug, 2025 Source: Department for Science, Innovation & Technology Country: United Kingdom Original Source

Brief

On Thursday 28 August, the Department for Science, Innovation & Technology announced a £29.6 million investment to establish the UK RNA Biofoundry in Darlington. This facility will accelerate the development and manufacturing of RNA therapies, which have shown promise in treating various diseases, including cancer, heart conditions, and infectious diseases.

This content is restricted.

Highlights content goes here...

This content is restricted.

Department for Science, Innovation & Technology

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Next-gen therapies for cancer, dementia and more fast-tracked with new facility

Brief

Department for Science, Innovation & Technology

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Next-gen therapies for cancer, dementia and more fast-tracked with new facility

Brief

Department for Science, Innovation & Technology

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.